H7N9 Solid Phase Completely Synthetic Replikins Vaccine Ready for Testing to Prevent Possible Pandemic

LONDON, April 9, 2013 /PRNewswire/ -- Bioradar UK Ltd and Replikins Ltd announced today that a new completely synthetic H7N9 Replikins Vaccine is ready for testing. The news comes on the heels of four new cases of avian flu (H7N9) reported in China, bringing the total to 28 cases, 8 of whom have died from the virus.

The new vaccine is produced without any biological substances and will be used without adjuvants, similar to the H5N1 Synthetic Replikins Vaccine which was found effective (1).

Contact: Email tel 646-320-5910

References
1.  Jackwood et al. Avian Diseases 53(4): 613‐617, 2009
2. <Replikins.com>

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

SOURCE Replikins Ltd